A consensus statement on the use of Clozapine during the COVID-19 outbreak developed by an expert advisory subgroup of the Treatment Response and Resistance in Psychosis working group may help providers and pharmacists understand the benefits and risks of reduced ANC blood monitoring during the current pandemic. Read the statement.
https://www.alliancehealthplan.org/wp-content/uploads/COVID-Grey.jpg 487 713 Lisa Brockmeier https://www.alliancehealthplan.org/wp-content/uploads/alliance-health-header.png Lisa Brockmeier2020-04-07 09:11:392020-04-07 09:12:08Consensus statement on the use of clozapine during the COVID-19 pandemic
Page last modified: April 7, 2020
Representatives are available 8:30am-5:15pm Monday-Friday to answer provider questions about authorization, billing, claims, enrollment and credentialing, the Alpha Provider Portal or other issues.